Organ preservation and perfusion solutions are specialized solutions used to maintain the viability and function of organs during transplantation or storage for medical purposes. These solutions are designed to provide optimal conditions for the preservation and transportation of organs from the donor to the recipient, ensuring minimal damage and maximizing the chances of a successful transplant.
Market Analysis and Insights: Global Organ Preservation and Perfusion Solution Market
The global Organ Preservation and Perfusion Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Organ Preservation and Perfusion Solution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Organ Preservation and Perfusion Solution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Organ Preservation and Perfusion Solution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Organ Preservation and Perfusion Solution include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz K枚hler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Organ Preservation and Perfusion Solution is widely used in various fields, such as Kidney, Liver, Heart and Lung, etc. Kidney provides greatest supports to the Organ Preservation and Perfusion Solution industry development. In 2023, global % revenue of Organ Preservation and Perfusion Solution went into Kidney filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Organ Preservation and Perfusion Solution market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Organ Preservation and Perfusion Solution, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Organ Preservation and Perfusion Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Organ Preservation and Perfusion Solution revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Organ Preservation and Perfusion Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Organ Preservation and Perfusion Solution revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz K枚hler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Segment by Application
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Organ Preservation and Perfusion Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ Preservation and Perfusion Solution companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organ Preservation and Perfusion Solution revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ Preservation and Perfusion Solution Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Static Cold Storage (SCS)
1.2.3 Hypothermic Perfusion Preservation (HPP)
1.2.4 Hypothermic Machine Preservation (HMP)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Organ Preservation and Perfusion Solution Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Kidney
1.3.3 Liver
1.3.4 Heart
1.3.5 Lung
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organ Preservation and Perfusion Solution Market Perspective (2019-2030)
2.2 Global Organ Preservation and Perfusion Solution Growth Trends by Region
2.2.1 Organ Preservation and Perfusion Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Organ Preservation and Perfusion Solution Historic Market Size by Region (2019-2024)
2.2.3 Organ Preservation and Perfusion Solution Forecasted Market Size by Region (2025-2030)
2.3 Organ Preservation and Perfusion Solution Market Dynamics
2.3.1 Organ Preservation and Perfusion Solution Industry Trends
2.3.2 Organ Preservation and Perfusion Solution Market Drivers
2.3.3 Organ Preservation and Perfusion Solution Market Challenges
2.3.4 Organ Preservation and Perfusion Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Organ Preservation and Perfusion Solution by Players
3.1.1 Global Organ Preservation and Perfusion Solution Revenue by Players (2019-2024)
3.1.2 Global Organ Preservation and Perfusion Solution Revenue Market Share by Players (2019-2024)
3.2 Global Organ Preservation and Perfusion Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Organ Preservation and Perfusion Solution, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Organ Preservation and Perfusion Solution Market Concentration Ratio
3.4.1 Global Organ Preservation and Perfusion Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ Preservation and Perfusion Solution Revenue in 2023
3.5 Global Key Players of Organ Preservation and Perfusion Solution Head office and Area Served
3.6 Global Key Players of Organ Preservation and Perfusion Solution, Product and Application
3.7 Global Key Players of Organ Preservation and Perfusion Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ Preservation and Perfusion Solution Breakdown Data by Type
4.1 Global Organ Preservation and Perfusion Solution Historic Market Size by Type (2019-2024)
4.2 Global Organ Preservation and Perfusion Solution Forecasted Market Size by Type (2025-2030)
5 Organ Preservation and Perfusion Solution Breakdown Data by Application
5.1 Global Organ Preservation and Perfusion Solution Historic Market Size by Application (2019-2024)
5.2 Global Organ Preservation and Perfusion Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Organ Preservation and Perfusion Solution Market Size (2019-2030)
6.2 North America Organ Preservation and Perfusion Solution Market Size by Type
6.2.1 North America Organ Preservation and Perfusion Solution Market Size by Type (2019-2024)
6.2.2 North America Organ Preservation and Perfusion Solution Market Size by Type (2025-2030)
6.2.3 North America Organ Preservation and Perfusion Solution Market Share by Type (2019-2030)
6.3 North America Organ Preservation and Perfusion Solution Market Size by Application
6.3.1 North America Organ Preservation and Perfusion Solution Market Size by Application (2019-2024)
6.3.2 North America Organ Preservation and Perfusion Solution Market Size by Application (2025-2030)
6.3.3 North America Organ Preservation and Perfusion Solution Market Share by Application (2019-2030)
6.4 North America Organ Preservation and Perfusion Solution Market Size by Country
6.4.1 North America Organ Preservation and Perfusion Solution Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Organ Preservation and Perfusion Solution Market Size by Country (2019-2024)
6.4.3 North America Organ Preservation and Perfusion Solution Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Organ Preservation and Perfusion Solution Market Size (2019-2030)
7.2 Europe Organ Preservation and Perfusion Solution Market Size by Type
7.2.1 Europe Organ Preservation and Perfusion Solution Market Size by Type (2019-2024)
7.2.2 Europe Organ Preservation and Perfusion Solution Market Size by Type (2025-2030)
7.2.3 Europe Organ Preservation and Perfusion Solution Market Share by Type (2019-2030)
7.3 Europe Organ Preservation and Perfusion Solution Market Size by Application
7.3.1 Europe Organ Preservation and Perfusion Solution Market Size by Application (2019-2024)
7.3.2 Europe Organ Preservation and Perfusion Solution Market Size by Application (2025-2030)
7.3.3 Europe Organ Preservation and Perfusion Solution Market Share by Application (2019-2030)
7.4 Europe Organ Preservation and Perfusion Solution Market Size by Country
7.4.1 Europe Organ Preservation and Perfusion Solution Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Organ Preservation and Perfusion Solution Market Size by Country (2019-2024)
7.4.3 Europe Organ Preservation and Perfusion Solution Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Organ Preservation and Perfusion Solution Market Size (2019-2030)
8.2 China Organ Preservation and Perfusion Solution Market Size by Type
8.2.1 China Organ Preservation and Perfusion Solution Market Size by Type (2019-2024)
8.2.2 China Organ Preservation and Perfusion Solution Market Size by Type (2025-2030)
8.2.3 China Organ Preservation and Perfusion Solution Market Share by Type (2019-2030)
8.3 China Organ Preservation and Perfusion Solution Market Size by Application
8.3.1 China Organ Preservation and Perfusion Solution Market Size by Application (2019-2024)
8.3.2 China Organ Preservation and Perfusion Solution Market Size by Application (2025-2030)
8.3.3 China Organ Preservation and Perfusion Solution Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Organ Preservation and Perfusion Solution Market Size (2019-2030)
9.2 Asia Organ Preservation and Perfusion Solution Market Size by Type
9.2.1 Asia Organ Preservation and Perfusion Solution Market Size by Type (2019-2024)
9.2.2 Asia Organ Preservation and Perfusion Solution Market Size by Type (2025-2030)
9.2.3 Asia Organ Preservation and Perfusion Solution Market Share by Type (2019-2030)
9.3 Asia Organ Preservation and Perfusion Solution Market Size by Application
9.3.1 Asia Organ Preservation and Perfusion Solution Market Size by Application (2019-2024)
9.3.2 Asia Organ Preservation and Perfusion Solution Market Size by Application (2025-2030)
9.3.3 Asia Organ Preservation and Perfusion Solution Market Share by Application (2019-2030)
9.4 Asia Organ Preservation and Perfusion Solution Market Size by Region
9.4.1 Asia Organ Preservation and Perfusion Solution Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Organ Preservation and Perfusion Solution Market Size by Region (2019-2024)
9.4.3 Asia Organ Preservation and Perfusion Solution Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Type
10.2.1 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Application
10.3.1 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Country
10.4.1 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Organ Preservation and Perfusion Solution Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 21st Century Medicine
11.1.1 21st Century Medicine Company Details
11.1.2 21st Century Medicine Business Overview
11.1.3 21st Century Medicine Organ Preservation and Perfusion Solution Introduction
11.1.4 21st Century Medicine Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.1.5 21st Century Medicine Recent Developments
11.2 Bridge to Life Limited
11.2.1 Bridge to Life Limited Company Details
11.2.2 Bridge to Life Limited Business Overview
11.2.3 Bridge to Life Limited Organ Preservation and Perfusion Solution Introduction
11.2.4 Bridge to Life Limited Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.2.5 Bridge to Life Limited Recent Developments
11.3 BioLife Solutions
11.3.1 BioLife Solutions Company Details
11.3.2 BioLife Solutions Business Overview
11.3.3 BioLife Solutions Organ Preservation and Perfusion Solution Introduction
11.3.4 BioLife Solutions Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.3.5 BioLife Solutions Recent Developments
11.4 Dr. Franz K枚hler Chemie GmbH
11.4.1 Dr. Franz K枚hler Chemie GmbH Company Details
11.4.2 Dr. Franz K枚hler Chemie GmbH Business Overview
11.4.3 Dr. Franz K枚hler Chemie GmbH Organ Preservation and Perfusion Solution Introduction
11.4.4 Dr. Franz K枚hler Chemie GmbH Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.4.5 Dr. Franz K枚hler Chemie GmbH Recent Developments
11.5 XVIVO Perfusion
11.5.1 XVIVO Perfusion Company Details
11.5.2 XVIVO Perfusion Business Overview
11.5.3 XVIVO Perfusion Organ Preservation and Perfusion Solution Introduction
11.5.4 XVIVO Perfusion Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.5.5 XVIVO Perfusion Recent Developments
11.6 Artivion
11.6.1 Artivion Company Details
11.6.2 Artivion Business Overview
11.6.3 Artivion Organ Preservation and Perfusion Solution Introduction
11.6.4 Artivion Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.6.5 Artivion Recent Developments
11.7 Preservation Solutions
11.7.1 Preservation Solutions Company Details
11.7.2 Preservation Solutions Business Overview
11.7.3 Preservation Solutions Organ Preservation and Perfusion Solution Introduction
11.7.4 Preservation Solutions Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.7.5 Preservation Solutions Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Details
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb Organ Preservation and Perfusion Solution Introduction
11.8.4 Bristol Myers Squibb Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Details
11.9.2 Teva Pharmaceuticals Business Overview
11.9.3 Teva Pharmaceuticals Organ Preservation and Perfusion Solution Introduction
11.9.4 Teva Pharmaceuticals Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.9.5 Teva Pharmaceuticals Recent Developments
11.10 Lifeline Scientific
11.10.1 Lifeline Scientific Company Details
11.10.2 Lifeline Scientific Business Overview
11.10.3 Lifeline Scientific Organ Preservation and Perfusion Solution Introduction
11.10.4 Lifeline Scientific Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.10.5 Lifeline Scientific Recent Developments
11.11 Advanced Life Solutions
11.11.1 Advanced Life Solutions Company Details
11.11.2 Advanced Life Solutions Business Overview
11.11.3 Advanced Life Solutions Organ Preservation and Perfusion Solution Introduction
11.11.4 Advanced Life Solutions Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.11.5 Advanced Life Solutions Recent Developments
11.12 Organ Recovery Systems
11.12.1 Organ Recovery Systems Company Details
11.12.2 Organ Recovery Systems Business Overview
11.12.3 Organ Recovery Systems Organ Preservation and Perfusion Solution Introduction
11.12.4 Organ Recovery Systems Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.12.5 Organ Recovery Systems Recent Developments
11.13 Transmedics
11.13.1 Transmedics Company Details
11.13.2 Transmedics Business Overview
11.13.3 Transmedics Organ Preservation and Perfusion Solution Introduction
11.13.4 Transmedics Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.13.5 Transmedics Recent Developments
11.14 Accord Healthcare
11.14.1 Accord Healthcare Company Details
11.14.2 Accord Healthcare Business Overview
11.14.3 Accord Healthcare Organ Preservation and Perfusion Solution Introduction
11.14.4 Accord Healthcare Revenue in Organ Preservation and Perfusion Solution Business (2019-2024)
11.14.5 Accord Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz K枚hler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
听
听
*If Applicable.
